Perbedaan Intiland Development Tbk. dan UBC Medical Indonesia Tbk.: Intiland Development Tbk. diperdagangkan di Rp115 (kapitalisasi pasar 1,2 T, volume 24 jam 12,33 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Intiland Development Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Intiland Development Tbk. lebih aktif diperdagangkan (12,33 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DILD | LABS | |
|---|---|---|
Kapitalisasi Pasar | 1,2 T | 584,6 M |
Volume | 12,33 jt | 817,3 rb |
Lot | 123,31 rb | 8,17 rb |
Perputaran | 1,42 M | 120,01 jt |
Harga Rata-rata | 115,27 | 146,84 |
Nilai Transaksi | 1,42 M | 120,01 jt |
Harga Ekuilibrium Indikatif | 115 | 146 |
Volume Ekuilibrium Indikatif | 33 | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Selengkapnya di halaman DILD →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →